These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4684132)

  • 1. [Pathogenesis of hypertension in primary aldosteronism].
    Distler A; Just HJ; Philipp T
    Dtsch Med Wochenschr; 1973 Jan; 98(3):100-5. PubMed ID: 4684132
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic characteristics of primary aldosteronism.
    Tarazi RC; Ibrahim MM; Bravo EL; Dustan HP
    N Engl J Med; 1973 Dec; 289(25):1330-5. PubMed ID: 4584836
    [No Abstract]   [Full Text] [Related]  

  • 3. [Endocrinologic and circulatory findings in a case of primary aldosteronism].
    Marsen B; Dissmann T; Oelkers W; Lohmann FW; Molzahn M; Gotzen R
    Dtsch Med Wochenschr; 1971 May; 96(22):951-4. PubMed ID: 5578596
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic findings in human arterial hypertension.
    Safar M; Milliez P
    Rev Eur Etud Clin Biol; 1972 Feb; 17(2):147-54. PubMed ID: 4262385
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential response to thiazides and spironolactone in primary aldosteronism.
    Gwinup G; Steinberg T
    Arch Intern Med; 1967 Oct; 120(4):436-43. PubMed ID: 6058098
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes.
    Wenting GJ; Man in 't Veld AJ; Derkx FH; Schalekamp MA
    Clin Exp Hypertens A; 1982; 4(9-10):1727-48. PubMed ID: 6754151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased gain in baroreceptor-heart rate reflex in patients with primary aldosteronism.
    Munakata M; Aihara A; Imai Y; Omata K; Abe K; Yoshinaga K
    J Hypertens; 1995 Dec; 13(12 Pt 2):1648-53. PubMed ID: 8903626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of aldosterone-induced hypertension in man.
    Distler A; Just HJ; Philipp T
    Clin Sci Mol Med; 1973 Dec; 45(6):743-50. PubMed ID: 4760033
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary hyperaldosteronism in a patient with end-stage renal disease.
    Kazory A; Weiner ID
    Nephrol Dial Transplant; 2007 Mar; 22(3):917-9. PubMed ID: 17127694
    [No Abstract]   [Full Text] [Related]  

  • 12. Spectral characteristics of heart rate and blood pressure variability in primary aldosteronism.
    Veglio F; Melchio R; Rabbia F; Molino P; Martini G; Chiandussi L
    Am J Hypertens; 1995 May; 8(5 Pt 1):479-86. PubMed ID: 7662224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How?].
    Herpin D; Sosner P; Amar J; Chamontin B
    Arch Mal Coeur Vaiss; 2003 Jan; 96(1):37-42. PubMed ID: 12613148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary hyperaldosteronism with malignant hypertension].
    Baglin A; Weiss Y; Safar M; Milliez P
    Nouv Presse Med; 1973 Feb; 2(5):295-7. PubMed ID: 4686221
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary aldosteronism: the most frequent form of secondary hypertension?
    Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypokalemic quadriparesis with normotensive primary hyperaldosteronism.
    Talib A; Mahmood K; Jairamani KL; Samo A; Shakoor A; Ghanghro I; Mehar S
    J Coll Physicians Surg Pak; 2004 Aug; 14(8):492-3. PubMed ID: 15321042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The etiopathology of hypertension.
    Siegenthaler W; Werning C
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):83-92. PubMed ID: 4321984
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperaldosteronism and the use of aldactone in cardiac insufficiency].
    Korochkin IM; Matveeva IV; Sidorenko BA; Arshakuni RO
    Kardiologiia; 1968 Dec; 8(12):74-81. PubMed ID: 5736746
    [No Abstract]   [Full Text] [Related]  

  • 19. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.